Professor, Medicine, University Massachusetts Medical School
Hematology
Dr. Alan Rosmarin, MD
|
|
Give Review
Dr. Alan Rosmarin is an expert in the field of Hematology. He studied medicine at Rutgers Robert Wood Johnson Medical School. Rutgers Robert Wood Johnson Medical School has a rank of 74 in research and a 67 in primary care He received 2 awards: "Regional Top Doctor" and "Meaningful Use Stage 1 Certification". Alan Rosmarin is also published. He has 32 publications published. The lastest publication: "An enhancer located between the neutrophil elastase and proteinase 3 promoters is activated by Sp1 and an Ets factor.' He is registered with Medicare and accepts Medicare payments.
Publications
- GABP Transcription Factor (Nuclear Respiratory Factor 2) is Required for Mitochondrial Biogenesis.
- GABP transcription factor is required for development of chronic myelogenous Leukemia via its control of PRKD2.
- p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell Lung carcinoma.
- Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric Cancer: a phase I study.
- Sp1 and C/EBP are necessary to activate the lactoferrin gene promoter during Myeloid differentiation.
- Diagnosis in oncology. Case 1: primary transmural cardiac Lymphoma.
- Characterization and localization to chromosome 7 of psihGABPalpha, a human processed pseudogene related to the ets transcription factor, hGABPalpha.
- Activation of utrophin promoter by heregulin via the ets-related transcription factor complex GA-binding protein alpha/beta.
- An enhancer located between the neutrophil elastase and proteinase 3 promoters is activated by Sp1 and an Ets factor.
- Sp1 cooperates with the ets transcription factor, GABP, to activate the CD18 (beta2 leukocyte integrin) promoter.
- GABP cooperates with c-Myb and C/EBP to activate the neutrophil elastase promoter.
- Scanning mutagenesis to localize DNA-protein interactions.
- CD18 (beta 2 leukocyte integrin) promoter requires PU.1 transcription factor for Myeloid activity.
- Differential regulation of JunD by dihydroxycholecalciferol in human chronic myelogenous Leukemia cells.
- GABP and PU.1 compete for binding, yet cooperate to increase CD18 (beta 2 leukocyte integrin) transcription.
- Differential expression of CD11b/CD18 (Mo1) and myeloperoxidase genes during Myeloid differentiation.
- Analysis of the mechanism of anagrelide-induced thrombocytopenia in humans.
- Cloning and analysis of the CD18 promoter.
- Characterization of the Myeloid-specific CD11b promoter.
- Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHL.
- GABP transcription factor is required for Myeloid differentiation, in part, through its control of Gfi-1 expression.
- Retrospective analysis of the efficacy of gemcitabine for previously treated AIDS-associated Kaposi''s sarcoma in western Kenya.
- PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced Leukemias in mice.
- Retinoic acid signaling in myelopoiesis.
- The Ets transcription factor GABP is required for cell-cycle progression.
- GA-binding protein and p300 are essential components of a retinoic acid-induced enhanceosome in Myeloid cells.
- Transcriptional regulation in myelopoiesis: Hematopoietic fate choice, Myeloid differentiation, and leukemogenesis.
- Sp1 control of gene expression in Myeloid cells.
- GA-binding protein transcription factor: a review of GABP as an integrator of intracellular signaling and protein-protein interactions.
- GA-binding protein (GABP) and Sp1 are required, along with retinoid receptors, to mediate retinoic acid responsiveness of CD18 (beta 2 leukocyte integrin): a novel mec...
- Sp1 and the ets-related transcription factor complex GABP alpha/beta functionally cooperate to activate the utrophin promoter.
Schools
Rutgers Medical School
Beth Israel Hospital
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
Education
-
Beth Israel Deaconess Medical Center -
Rutgers Robert Wood Johnson Medical School
Hospital
-
UMass Memorial Medical Center
Drug Facts
| NPI NUMBER | 1225040025 | |
| NPPES Provider LastName | ROSMARIN | |
| NPPES Provider FirstName | ALAN | |
| NPPES Provider ZIPCode | 016550002 | |
| NPPES Provider State | MA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 88.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1225040025 |
| Last Name Of The Provider | ROSMARIN |
| First Name Of The Provider | ALAN |
| View All |
Similar Doctors
|
|
Dr. Charles V. Kurkul, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James D. O'Shea, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Louis M. Snyder, MD |
|
|
Dr. Glen D. Raffel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Liberto Pechet, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hongbo Yu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suyang Hao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ellen Scepansky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Herbert M. Dean, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tony M. Samaha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amr R. Hassan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Doreen B. Brettler, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. David S. Shepro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zheng Zhou, MD
This Doctor is OpenDoctor Recommended.
|